Effect of Different Doses of Sodium Fluoride on Various Hydroxyproline Fractions in Rat Kidneys

2010 ◽  
Vol 1 (1) ◽  
pp. 33-40 ◽  
Author(s):  
E.A. Al-Omireen ◽  
N.J. Siddiqi ◽  
A.S. Alhomida
Keyword(s):  
Sodium Fluoride ◽  
Different Doses ◽  
Rat Kidneys

Protective Effects of Curcumin against Sodium Fluoride-Induced Toxicity in Rat Kidneys

2011 ◽  
Vol 145 (3) ◽  
pp. 369-374 ◽  
Author(s):  
Seyed Fazel Nabavi ◽  
Akbar Hajizadeh Moghaddam ◽  
Shahram Eslami ◽  
Seyed Mohammad Nabavi
Keyword(s):  
Sodium Fluoride ◽  
Protective Effects ◽  
Rat Kidneys

scholarly journals ALLEVIATION OF FLUORIDE INDUCED ALTERATIONS IN ANTIOXIDANT STATUS AND FECUNDITY OF SPERMATOZOA OF RATS BY BOERHAAVIA DIFFUSA L.

2017 ◽  
Vol 9 (10) ◽  
pp. 93
Author(s):  
Shashi A. Shashi A. ◽  
Imtiaza Khan
Keyword(s):  
Sodium Fluoride ◽  
Antioxidant Status ◽  
Sperm Count ◽  
Experimental Period ◽  
Male Rats ◽  
Control Group ◽  
Ameliorative Effect ◽  
Dose Dependent ◽  
Boerhaavia Diffusa ◽  
Different Doses

Objective: The present study focused on the effect of oral administration of sodium fluoride on antioxidant status and fecundity of spermatozoa of rats and also to evaluate the ameliorative effect of Boerhaavia diffusa L.Methods: Wistar male rats (weighing 100-150g) were administered sodium fluoride (at three different doses 100, 200 and 300 ppm/kg BW) daily for 20 and 40 d. At the end of the experimental period, half of the animals were sacrificed and their epididymis was removed. Remaining half rats were administered B. diffusa (250 and 500 mg/kg BW) for 20 d. Level of malondialdehyde (MDA), the activity of superoxide dismutase (SOD) and catalase (CAT) was estimated. Sperm morphology, count, motility and viability were also determined.Results: There was a dose-dependent significant decrease in activity of SOD (p<0.01) and CAT (p<0.05), and increase (p<0.01) in the level of MDA in experimental rats as compared to the control group. Sperm count, motility and viability were also decreased significantly (p<0.0001) in rats treated with fluoride. The fluorotic rats exhibited morphological abnormalities in the head (amorphous, hookless, double headed and bent), tail (coiled, hairpin looped, double-tailed) and body (short, large and presence of protoplasmic process) of spermatozoa as compared to control group. These toxic effects were reversed by the administration of leaf extract of Boerhaavia diffusa L.Conclusion: The results suggest that Boerhaavia diffusa L. extract attenuates fluoride exerted disruptions to spermatozoa

No effect of vitamin D supplementation on metabolic parameters but on lipids in patients with type 2 diabetes and chronic kidney disease

2020 ◽  
pp. 1-10
Author(s):  
Jiwoon Kim ◽  
Ji Sun Nam ◽  
Heejung Kim ◽  
Hye Sun Lee ◽  
Jung Eun Lee
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Vitamin D ◽  
Kidney Disease ◽  
Vitamin D Supplementation ◽  
Lipid Profiles ◽  
Metabolic Parameters ◽  
Injection Group ◽  
Different Doses

Abstract. Background/Aims: Trials on the effects of cholecalciferol supplementation in type 2 diabetes with chronic kidney disease patients were underexplored. Therefore, the aim of this study was to investigate the effects of two different doses of vitamin D supplementation on serum 25-hydroxyvitamin D [25(OH)D] concentrations and metabolic parameters in vitamin D-deficient Korean diabetes patients with chronic kidney disease. Methods: 92 patients completed this study: the placebo group (A, n = 33), the oral cholecalciferol 1,000 IU/day group (B, n = 34), or the single 200,000 IU injection group (C, n = 25, equivalent to 2,000 IU/day). 52% of the patients had less than 60 mL/min/1.73m2 of glomerular filtration rates. Laboratory test and pulse wave velocity were performed before and after supplementation. Results: After 12 weeks, serum 25(OH)D concentrations of the patients who received vitamin D supplementation were significantly increased (A, -2.4 ± 1.2 ng/mL vs. B, 10.7 ± 1.2 ng/mL vs. C, 14.6 ± 1.7 ng/mL; p < 0.001). In addition, the lipid profiles in the vitamin D injection group (C) showed a significant decrease in triglyceride and a rise in HDL cholesterol. However, the other parameters showed no differences. Conclusions: Our data indicated that two different doses and routes of vitamin D administration significantly and safely increased serum 25(OH)D concentrations in vitamin D-deficient diabetes patients with comorbid chronic kidney disease. In the group that received the higher vitamin D dose, the lipid profiles showed significant improvement, but there were no beneficial effects on other metabolic parameters.

Kinetics and mechanism of the reduction of selenium (IV) by iron (II) in presence of sodium fluoride

1973 ◽  
Vol 70 ◽  
pp. 918-922 ◽  
Author(s):  
R. K. Srivastava ◽  
V. K. Srivastava ◽  
M. N. Srivastava ◽  
B. B. L. Saxena
Keyword(s):  
Sodium Fluoride ◽  
Kinetics And Mechanism

18F-sodium fluoride bone deposition quantitation with PET in Mice: Variation with age, sex, and circadian rhythm

2020 ◽  
Vol 59 (06) ◽  
pp. 428-437
Author(s):  
Viktoria Dorau-Rutke ◽  
Kai Huang ◽  
Mathias Lukas ◽  
Marc O. Schulze ◽  
Christian Rosner ◽  
...  
Keyword(s):  
Circadian Rhythm ◽  
Sodium Fluoride ◽  
Bone Growth ◽  
Bone Volume ◽  
Sleep Phase ◽  
Median Percentage ◽  
Bone Uptake ◽  
Pooled Data ◽  
Uptake Studies ◽  
Bone Deposition

Abstract Aim The aim of this study was to establish a data base for normal 18F-sodium fluoride (18F-NaF) bone uptake as a function of age, sex and circadian rhythm in mice. Methods In 12 female (F) and 12 male (M) C57BL/6N mice PET images were acquired 90 min after intravenous injection of 20 MBq 18F-NaF for 30 minutes. Each mouse was imaged in follow-up studies at 1, 3, 6, 13 and 21 months of age. In order to assess for physiologic changes related to circadian rhythm, animals were imaged during light (sleep phase) as well as during night conditions (awake phase). Bone uptake is described as the median percentage of the injected activity (%IA) and in relation to bone volume (%IA/ml). Results A significant smaller bone volume was found in F (1.79 ml) compared to M (1.99 ml; p < 0.001). In sex-pooled data, highest bone uptake occurred at an age of 1 month (61.1 %IA, 44.5 %IA/ml) with a significant reduction (p < 0.001) at age 3 months (43.6 %IA, 23.6 %IA/ml), followed by an increase between 13 (47.3 %IA, 24.5 %IA/ml) and 21 months (52.2 %IA, 28.1 %IA/ml). F had a significantly higher total uptake (F 48.2 %IA, M 43.8 %IA; p = 0.026) as well as a higher uptake per ml bone tissue (F 27.0 %IA/ml; M 22.4 %IA/ml; p < 0.001). A significant impact of circadian rhythm was only found for F at ages of 3 and 6 months with a higher uptake during the sleep phase. Conclusion Circadian rhythm had a significant impact on uptake only in F of 3 and 6 months. Regarding sex, F showed generally higher uptake rates than M. The highest uptake values were observed during bone growth at age 1 month in both sexes, a second uptake peak occurred in elderly F. Designing future bone uptake studies with M, attention must be paid to age only, while in F circadian rhythm and age must be taken into account.

99mTechnetium-Unithiol Complex, a New Pharmaceutical for Kidney Scintigraphy

1976 ◽  
Vol 15 (06) ◽  
pp. 282-286 ◽  
Author(s):  
M. Rembelska ◽  
M. Ogiński
Keyword(s):  
Paper Chromatography ◽  
Rat Kidneys

SummaryThe investigations were carried out with a newly syn-thesised, original 99mTc-Unithiol complex (Unithiol-2,3-dimercaptopropansulphonate). It accumulates in the kidneys and enables their scintigraphic examination at 90—180 minutes after the administration. The study was performed on rats, rabbits and dogs. 99mTc-Unithiol complex accumulation in rat kidneys was 34,9%, 44,5% and 67,8% of dose after 1, 2 and 3 h respectively.Good reability of the scintigraphic picture of the kidneys in rabbits and dogs confirms the accumulative capability of the complex in these organs. It was found by means of ascending paper chromatography that the purity of the 99mTc-Unithiol complex exceeded 90%.

Effects of Two Different Doses of Hirudin on APTT, Determined with Eight Different Reagents

1995 ◽  
Vol 73 (02) ◽  
pp. 219-222 ◽  
Author(s):  
Manuel Monreal ◽  
Luis Monreal ◽  
Rafael Ruiz de Gopegui ◽  
Yvonne Espada ◽  
Ana Maria Angles ◽  
...  
Keyword(s):  
Ex Vivo ◽  
Anticoagulant Activity ◽  
Subcutaneous Administration ◽  
In Vitro Study ◽  
Ex Vivo Model ◽  
Suitable Candidate ◽  
Significant Prolongation ◽  
High Doses ◽  
Different Doses

SummaryThe APTT has been considered the most suitable candidate to monitor the anticoagulant activity of hirudin. However, its use is hampered by problems of standardization, which make the results heavily dependent on the responsiveness of the reagent used. Our aim was to investigate if this different responsiveness of different reagents when added in vitro is to be confirmed in an ex vivo study.Two different doses of r-hirudin (CGP 39393), 0.3 mg/kg and 1 mg/kg, were administered subcutaneously to 20 New Zealand male rabbits, and the differences in prolongation of APTT 2 and 12 h later were compared, using 8 widely used commercial reagents. All groups exhibited a significant prolongation of APTT 2 h after sc administration of hirudin, both at low and high doses. But this prolongation persisted 12 h later only when the PTTa reagent (Boehringer Mannheim) was used. In general, hirudin prolonged the APTT most with the silica- based reagents.In a further study, we compared the same APTT reagents in an in vitro study in which normal pooled plasma was mixed with increasing amount of hirudin. We failed to confirm a higher sensitivity for silica- containing reagents. Thus, we conclude that subcutaneous administration of hirudin prolongs the APTT most with the silica-based reagents, but this effect is exclusive for the ex vivo model.

Dose Requirement for Replacement Therapy in Hemophilia A

1979 ◽  
Vol 42 (03) ◽  
pp. 825-831 ◽  
Author(s):  
Jean-Pierre Allain
Keyword(s):  
Clinical Effect ◽  
Hemophilia A ◽  
Clinical Results ◽  
Severe Hemophilia ◽  
Dose Requirement ◽  
Viii Level ◽  
The Relationship ◽  
In Vivo Recovery ◽  
Different Doses

SummaryIn order to determine the correlation between different doses of F. VIII and their clinical effect,. 70 children with severe hemophilia A were studied after treatment with single doses of cryoprecipitate. The relationship between plasma F. VIII levels or doses calculated in u/ kg of body weight and clinical results followed an exponential curve. Plasma F. VIII levels of 0.35 and 0.53 u/ml corresponded to 95 and 99% satisfactory treatment, respectively. Similar clinical results were obtained with 20 and 31 u/kg. When the in vivo recovery of F. VIII after lyophilized cryoprecipitate was 0.015 u/ml for each u/kg injected, plasma F. VIII levels of 0.30 and 0.47 u/ml respectively were achieved. Since home treatment is largely based on single infusions of F. VIII, it is suggested that moderate and severe hemorrhages be treated with a dose which will provide a plasma F. VIII level of 0.5 u/ml.

Clearance and In Vivo Release by Heparin of Human Platelet Factor 4 (PF4) in the Rabbit

1984 ◽  
Vol 52 (02) ◽  
pp. 157-159 ◽  
Author(s):  
M Prosdocimi ◽  
N Scattolo ◽  
A Zatta ◽  
F Fabris ◽  
F Stevanato ◽  
...  
Keyword(s):  
Half Life ◽  
Human Platelet ◽  
Slow Component ◽  
Platelet Factor 4 ◽  
Platelet Factor ◽  
In Vivo Release ◽  
Partial Release ◽  
Different Doses ◽  
New Zealand Rabbits

Summary13 male New Zealand rabbits were injected with two different doses (25 μg/Kg and 100 μg/Kg) of human platelet factor 4 antigen (PF4). The disappearance of the protein was extremely fast with an half-life for the fast component of 1.07 ± 0.16 and 1.76 ± 0.11 min respectively. The half-life for the slow component, detectable only with the highest dosage, was 18.8 min.The administration of 2500 I.U. of heparin 30 min after PF4 administration induced a partial release of the injected protein and its clearance from plasma was slow, with half-life of 23.3 ± 5.9 min and 30.9 ± 2.19 min respectively.

Sign in / Sign up

Export Citation Format

Share Document